Wednesday, July 24, 2024

LA-based Pearl, an FDA-approved startup that uses AI to assist dentists to make diagnoses, raised a $58M Series B led by Left Lane Capital at a $400M valuation (Katie Roof/Bloomberg)

Katie Roof / Bloomberg:
LA-based Pearl, an FDA-approved startup that uses AI to assist dentists to make diagnoses, raised a $58M Series B led by Left Lane Capital at a $400M valuation  —  - Los Angeles-based startup backed by Craft Ventures, Left Lane  — Pearl is valued at $400 million in fresh financing deal



No comments:

Post a Comment

Sources: JPMorgan Chase terminated its banking relationship with Polymarket in 2025 over regulatory concerns, though it still maintains some ties to the company (Financial Times)

Financial Times : Sources: JPMorgan Chase terminated its banking relationship with Polymarket in 2025 over regulatory concerns, though it...